Monitoring of BCR-ABL levels in chronic myeloid leukemia patients treated with imatinib in the chronic phase - the importance of a major molecular response

BACKGROUND: Real time PCR has become the most common technique to monitor BCR-ABL transcript levels of patients treated with kinase inhibitors. The aim of this study was to evaluate BCR-ABL levels of chronic myeloid leukemia patients treated with imatinib in the chronic phase and correlate the respo...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Machado, Melissa Pereira, Tomaz, Juarez Pires, Lorand-Metze, Irene, de Souza, Cármino Antonio, Vigorito, Afonso Celso, Delamain, Marcia Torresan, Bendit, Israel, Pereira, Noemi Farah, Pagnano, Katia Borgia Barbosa
Format: Artigo
Idioma:Inglês
Publicat: Associação Brasileira de Hematologia e Hemoterapia 2011
Matèries:
Original Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3415739/
https://ncbi.nlm.nih.gov/pubmed/23049298
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5581/1516-8484.20110056
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars